WILSON TROY EDWARD

CIK 00015895975 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001589597

Recent Transactions

50 trades

Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2026-06-12$7.20/sh−10,800→ 59,750 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2026-06-11+27,000→ 70,550 total
Exercise/Conversion
Kura Oncology, Inc.$KURA
Common Stock
2026-03-23$6.15/sh+6,103→ 435,456 total
Exercise/Conversion
Kura Oncology, Inc.$KURA
Stock Option (Right to Buy)
2026-03-23+6,103→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−65,091→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−15,000→ 0 total
Award
Atrium Therapeutics, Inc.$RNA
Stock Option (Right to Buy)
2026-02-27+20,000→ 20,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−13,489→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−10,034→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−13,711→ 0 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2026-01-02+1,120,000→ 1,120,000 total
Award
Kura Oncology, Inc.$KURA
Common Stock
2025-11-13+182,500→ 429,353 total
Sale
Kura Oncology, Inc.$KURA
Common Stock
2025-09-29$8.94/sh−36,615→ 246,853 total
Award
Kura Oncology, Inc.$KURA
Common Stock
2025-09-27+182,500→ 283,468 total
Purchase
Kura Oncology, Inc.$KURA
Common Stock
2025-09-08$8.20/sh+50,000→ 100,968 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-09-05−14,500→ 0 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-05$12.48/sh+14,500→ 83,925 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-05$50.00/sh−14,500→ 69,425 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-05$50.00/sh−15,000→ 54,425 total
Purchase
Kura Oncology, Inc.$KURA
Common Stock
2025-08-13$6.64/sh+13,494→ 50,968 total
Purchase
Kura Oncology, Inc.$KURA
Common Stock
2025-08-12$5.85/sh+36,506→ 37,474 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$12.03/sh+22,000→ 91,425 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−7,500→ 69,425 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−15,000→ 285,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−17,777→ 17,776 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−15,000→ 285,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−17,777→ 17,776 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$45.00/sh−22,000→ 69,425 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$12.48/sh+7,500→ 76,925 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−7,500→ 14,500 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−22,000→ 0 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-13$3.40/sh−10,800→ 43,550 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-11+27,000→ 54,350 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-06-10+10,034→ 10,034 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-06-10+6,692→ 69,425 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2025-01-02+625,000→ 625,000 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-18+27,000→ 27,350 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-13$3.33/sh−27,000→ 350 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-06-13+13,489→ 13,489 total
Exercise/Conversion
Kura Oncology, Inc.$KURA
Common Stock
2024-01-24$6.15/sh+84,107→ 84,666 total
Exercise/Conversion
Kura Oncology, Inc.$KURA
Common Stock
2024-01-24$4.80/sh+6,945→ 7,504 total
Sale
Kura Oncology, Inc.$KURA
Common Stock
2024-01-24$20.23/sh−6,945→ 559 total
Sale
Kura Oncology, Inc.$KURA
Common Stock
2024-01-24$20.23/sh−84,107→ 559 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2024-01-02+560,000→ 560,000 total
Other
Avidity Biosciences, Inc.$RNAM
Common Stock
2023-12-12+250,000→ 300,000 total
Other
Avidity Biosciences, Inc.$RNAM
Common Stock
2023-12-12−300,000→ 263,711 total
Other
Avidity Biosciences, Inc.$RNAM
Common Stock
2023-12-12−250,000→ 13,711 total
Other
Avidity Biosciences, Inc.$RNAM
Common Stock
2023-12-12+300,000→ 300,000 total
Gift
Kura Oncology, Inc.$KURA
Common Stock
2023-12-07−1,000→ 279,194 total
Gift
Kura Oncology, Inc.$KURA
Common Stock
2023-12-07−2,000→ 559 total

Companies

Recent Filings

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 1700

LOS ANGELES, CA, 90024

View on SEC.gov